info@synchemia.com | sales@synchemia.com 
9766925136 
Deucravacitinib
Deucravacitinib | CAS NO:1609392-27-9 , Deucravacitinib is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).Deucravacitinib is a breakthrough in the targeted treatment of moderate-to-severe plaque psoriasis.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Deucravacitinib impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Deucravacitinib is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Deucravacitinib is in a class of medications called selective serotonin receptor agonists.. Buy Reliable and High-Purity Deucravacitinib Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-D3497 |
| CAS No | 2417137-50-7 |
| Mol.F. | C20H22N8O3 |
| Mol.Wt. | 422.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3498 |
| CAS No | 1352925-63-3 |
| Mol.F. | C7H8N2O4 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3499 |
| CAS No | 2761695-60-5 |
| Mol.F. | C17H17ClN6O3 |
| Mol.Wt. | 388.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3500 |
| CAS No | 2417138-49-7 |
| Mol.F. | C16H16ClN7O2 |
| Mol.Wt. | 373.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3501 |
| CAS No | 2245111-21-9 |
| Mol.F. | C10H9ClN4O3 |
| Mol.Wt. | 268.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3502 |
| CAS No | 3054860-97-5 |
| Mol.F. | C10H11ClN4O |
| Mol.Wt. | 238.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3503 |
| CAS No | 679406-03-2 |
| Mol.F. | C7H6Cl2N2O2 |
| Mol.Wt. | 221.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3504 |
| CAS No | NA |
| Mol.F. | C10H11N3O |
| Mol.Wt. | 189.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3505 |
| CAS No | NA |
| Mol.F. | C8H10N2OS |
| Mol.Wt. | 182.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3506 |
| CAS No | 2245111-18-4 |
| Mol.F. | C19H19N7O4 |
| Mol.Wt. | 409.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3507 |
| CAS No | 1040246-87-4 |
| Mol.F. | C5H2Cl2N2O2 |
| Mol.Wt. | 193.0 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-D3508 |
| CAS No | 1261798-87-1 |
| Mol.F. | C5H3ClN2O2 |
| Mol.Wt. | 158.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3509 |
| CAS No | 1509180-81-7 |
| Mol.F. | C5H3ClN2O3 |
| Mol.Wt. | 174.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3510 |
| CAS No | 1782896-18-7 |
| Mol.F. | C5H3ClN2O3 |
| Mol.Wt. | 174.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3511 |
| CAS No | 1823277-97-9 |
| Mol.F. | C5H4N2O4 |
| Mol.Wt. | 156.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3512 |
| CAS No | 3026065-02-8 |
| Mol.F. | C9H10N4O |
| Mol.Wt. | 190.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
